AMGEN INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Amgen Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Amgen Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.71B, a 108% decline year-over-year.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21B.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$4.04B, a 51.2% increase from 2021.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$8.27B, a 69.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21B +$25.1B Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
2022 -$4.04B +$4.23B +51.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
2021 -$8.27B -$3.4B -69.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 -$4.87B +$10.9B +69.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 -$15.8B +$6.72B +29.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-16
2018 -$22.5B -$15.9B -241% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 -$6.59B -$4B -154% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
2016 -$2.6B +$1.17B +31.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 -$3.77B -$497M -15.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 -$3.27B -$5.77B -231% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $2.49B +$2.07B +495% Jan 1, 2013 Dec 31, 2013 8-K 2016-10-31
2012 $419M +$1.09B Jan 1, 2012 Dec 31, 2012 10-K 2015-02-19
2011 -$674M +$558M +45.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 -$1.23B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.